Andrew Combs
Corporate Officer/Principal bei PRELUDE THERAPEUTICS INCORPORATED
Vermögen: - $ am 31.03.2024
Profil
Andrew P.
Combs is currently the Executive Vice President & Head-Chemistry at Prelude Therapeutics, Inc. He was previously the Vice President at Incyte Corp.
Prior to that, he held Director-Medicinal Chemistry positions at DuPont Pharmaceuticals Co. and DuPont Merck Pharmaceutical Co. and was also the Director-Medicinal Pharmaceuticals at Bristol Myers Squibb Co. Combs holds a doctorate from the University of California, Los Angeles and an undergraduate degree from the University of Wisconsin.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Andrew Combs
| Unternehmen | Position | Beginn |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Corporate Officer/Principal | 01.04.2019 |
Ehemalige bekannte Positionen von Andrew Combs
| Unternehmen | Position | Ende |
|---|---|---|
| INCYTE CORPORATION | Director of Finance/CFO | 01.01.2015 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2003 |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a private company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Corporate Officer/Principal | 01.08.2002 |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Corporate Officer/Principal | 01.08.2002 |
Ausbildung von Andrew Combs
| University of California, Los Angeles | Doctorate Degree |
| University of Wisconsin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| INCYTE CORPORATION | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Health Technology |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a private company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
